| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 3, 2002
* To whom correspondence should be addressed. E-mail: gtsujimoto{at}nch.go.jp
.
AbstractIn
an attempt to elucidate whether there is a specific
Revised on April 16, 2002
Role of the
Akito Tanoue;
1D-Adrenegric
Receptor in the Development of Salt-Induced
Hypertension
1-adrenergic receptor
(
1-AR) subtype involved in the genesis or
maintenance of hypertension, the
1D-AR subtype was evaluated in a model of
salt-induced hypertension. The
1D-AR--deficient
(
1D-/-) and
control (
1D+/+)
mice (n=8 to 14 in each group) were submitted to subtotal nephrectomy
and given 1% saline as drinking water for 35 days. Blood pressure (BP)
was monitored by tail-cuff readings and confirmed at the end point by
direct intraarterial BP recording. The
1D-/- mice had
a significantly (P=0.0004)
attenuated increase in BP response in this protocol (baseline 94.6±2.8
versus end point 107.4±4.5 mm Hg) compared with that of their
wild-type counterparts
(
1D+/+), from a
baseline 97.4±2.9 to an end point 139.4±4.5 mm Hg. Seven of 15
1D+/+ mice died
with edema, probably owing to renal failure, whereas 14 of 15
1D-/- mice
were maintained for 35 days. Body weight, renal remnant weight, and
residual renal function were similar in the 2 groups, whereas the
values of plasma catecholamines (epinephrine,
norepinephrine, and dopamine) were higher in
1D+/+ than in the
1D-/- mice.
These data suggest that
1D-AR plays an
important role in developing a high BP in response to dietary
salt-loading, and that agents having selective
1D-AR antagonism could have significant
therapeutic potential in the treatment of
hypertension.
This article has been cited by other articles:
![]() |
E. Oliver, D. Marti, F. Monto, N. Flacco, L. Moreno, D. Barettino, M. D. Ivorra, and P. D'Ocon The Impact of {alpha}1-Adrenoceptors Up-Regulation Accompanied by the Impairment of {beta}-Adrenergic Vasodilatation in Hypertension J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 982 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Cohn, D. M. Harris, S. Pesant, M. Pfeiffer, R.-H. Zhou, W. J. Koch, G. W. Dorn 2nd, and A. D. Eckhart Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances {alpha}1D-adrenergic receptor constriction Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1695 - H1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lyssand, M. C. DeFino, X.-b. Tang, A. L. Hertz, D. B. Feller, J. L. Wacker, M. E. Adams, and C. Hague Blood Pressure Is Regulated by an {alpha}1D-Adrenergic Receptor/Dystrophin Signalosome J. Biol. Chem., July 4, 2008; 283(27): 18792 - 18800. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, T. W. Moon, K. R. Olson, R. A. Dombkowski, and S. F. Perry The effects of salt-induced hypertension on {alpha}1-adrenoreceptor expression and cardiovascular physiology in the rainbow trout (Oncorhynchus mykiss) Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1384 - R1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hosoda, M. Hiroyama, A. Sanbe, J.-i. Birumachi, T. Kitamura, S. Cotecchia, P. C. Simpson, G. Tsujimoto, and A. Tanoue Blockade of both {alpha}1A- and {alpha}1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H514 - H519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hosoda, T.-a. Koshimizu, A. Tanoue, Y. Nasa, R. Oikawa, T. Tomabechi, S. Fukuda, H. Shinoura, S. Oshikawa, S. Takeo, et al. Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation Mol. Pharmacol., March 1, 2005; 67(3): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Wall, Y. H. Kim, L. Stanley, D. M. Glapion, L. A. Everett, E. D. Green, and J. W. Verlander NaCl Restriction Upregulates Renal Slc26a4 Through Subcellular Redistribution: Role in Cl- Conservation Hypertension, December 1, 2004; 44(6): 982 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and J. E. Faber Gene deletion of dopamine {beta}-hydroxylase and {alpha}1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2106 - H2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors Cardiovasc Res, September 1, 2004; 63(4): 662 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Gates, H. Tanaka, W. R. Hiatt, and D. R. Seals Dietary Sodium Restriction Rapidly Improves Large Elastic Artery Compliance in Older Adults With Systolic Hypertension Hypertension, July 1, 2004; 44(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Jones Dietary Sodium and Blood Pressure Hypertension, May 1, 2004; 43(5): 932 - 935. [Full Text] [PDF] |
||||
![]() |
C. Hague, Z. Chen, A. S. Pupo, N. A. Schulte, M. L. Toews, and K. P. Minneman The N Terminus of the Human {alpha}1D-Adrenergic Receptor Prevents Cell Surface Expression J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 388 - 397. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |